Danaher Corporation Logo

Danaher Corporation (DHR)

NYSE

Currency in USD
218.85
+2.94 (+1.36%)

Closed

Aug 21, 2026

Day's Range

213.46
220.25

52 wk Range

160.93
242.80

Profile - DHR - Danaher Corporation

Profile

Mic Code

XNYS

Sector

Healthcare

Industry

Diagnostics & Research

Employees

58K


Danaher Corporation is a leading science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. It operates primarily through three key segments: Biotechnology, which provides tools and services for bioprocessing, genomics, and proteomics; Life Sciences, offering advanced instrumentation for research in microscopy, flow cytometry, and mass spectrometry; and Diagnostics, delivering clinical instruments, software, and consumables for laboratory diagnostics, pathology, and healthcare settings. Danaher Corporation's portfolio includes diagnostic equipment, digital imaging systems, optical instruments, microscopes, water quality control systems, and disinfection solutions, serving healthcare providers, research institutions, pharmaceutical companies, and industrial clients. These offerings support critical applications in drug discovery, disease diagnosis, environmental monitoring, and quality assurance across global markets. Founded in 1984 and headquartered in Washington, District of Columbia, Danaher Corporation plays a vital role in advancing scientific innovation and improving health outcomes through its integrated solutions.

Profile Details

Type

Common Stock

Ceo

Mr. Rainer M. Blair

Address

2200 Pennsylvania Avenue N.W.

City

Washington

State

DC

Zip

20037-1701

Country

United States

Phone

202 828 0850

Key Executives - DHR - Danaher Corporation

Key executives

NamePositionAgePay
Mr. Rainer M. BlairPresident, CEO & Director616.11M
Dr. Martin Stumpe Ph.D.Chief Technology & AI Officer--
Mr. Christopher M. BoudaVP & Chief Accounting Officer--
Mr. Matthew E. Gugino C.F.A., CPAExecutive VP & CFO42-
Mr. Mitchell P. RalesCo-Founder & Director68-
Mr. Steven M. RalesCo-Founder & Chairman74-
Mr. Matthew R. McGrewExecutive Vice President533.17M
Ms. Julie Sawyer MontgomeryExecutive Vice President of Diagnostics Platform532.57M
Mr. Christopher Paul RileyExecutive VP of Biotechnology Group & CEO of Cytiva512.53M
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior VP & Chief Science Officer632.51M

Cross Listings - DHR - Danaher Corporation

Also listed on

The same company trading on other exchanges.

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.